CA Stock MarketDetailed Quotes

PREV PreveCeutical Medical Inc

Watchlist
  • 0.025
  • 0.0000.00%
15min DelayMarket Closed Jun 27 11:36 ET
13.50MMarket Cap-12500P/E (TTM)

PreveCeutical Medical Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
47.78%-222.64K
172,987.12%228.21K
-120.10%-46.61K
76.14%-161.25K
-1,469.12%-243.01K
-760.10%-426.39K
99.89%-132
-55.43%231.86K
-189.04%-675.86K
118.26%17.75K
Net income from continuing operations
14.20%-1.48M
171.16%333.89K
-37,161.94%-797.57K
45.44%-416.62K
-21.21%-601.06K
54.58%-1.73M
71.44%-469.18K
-99.52%2.15K
63.43%-763.65K
4.79%-495.9K
Operating gains losses
96.09%-789
--0
--0
--0
96.56%-789
-120.97%-20.19K
348.79%2.03K
-96.06%745
--0
---22.97K
Depreciation and amortization
94.28%9.89K
836.47%6.57K
-20.15%1.09K
-26.28%1.11K
-26.41%1.13K
-93.23%5.09K
-69.83%702
-24.74%1.36K
-94.82%1.5K
-96.36%1.53K
Asset impairment expenditure
--38.82K
----
----
----
----
--0
----
----
----
----
Remuneration paid in stock
270.96%334.11K
-124.11%-6.74K
2,562.01%308.23K
-3.40%19.99K
-57.67%12.62K
-92.29%90.07K
-97.10%27.97K
-19.03%11.58K
-89.08%20.7K
7,280.20%29.82K
Deferred tax
--0
----
----
----
----
-232.96%-20.48K
----
----
----
----
Other non cashItems
-41.52%381.81K
-269.20%-283.9K
268.52%297.71K
8.16%84.42K
-13.07%283.58K
-64.40%652.85K
56.19%167.79K
-4.12%80.79K
-94.80%78.06K
133.20%326.22K
Change In working capital
-16.52%494.89K
-52.04%139.58K
6.44%143.94K
1,301.97%149.85K
-65.64%61.53K
-15.10%592.85K
-35.35%291.03K
371.83%135.23K
-122.00%-12.47K
-25.78%179.05K
-Change in receivables
-106.59%-2.35K
34.68%3.18K
93.23%-493
-118.32%-5.76K
-92.10%726
486.99%35.72K
-60.91%2.36K
-157.80%-7.29K
281.89%31.47K
93.57%9.19K
-Change in prepaid assets
-370.15%-26.96K
-425.86%-21.77K
-238.07%-13.9K
170.53%15.17K
-143.79%-6.46K
-95.13%9.98K
-95.04%6.68K
177.69%10.07K
67.49%-21.51K
-90.14%14.74K
-Change in payables and accrued expense
-4.19%524.2K
-43.91%158.17K
19.54%158.33K
726.43%140.44K
-56.64%67.26K
12.31%547.14K
-8.89%281.99K
368.15%132.45K
-116.00%-22.42K
78.45%155.12K
Cash from discontinued investing activities
Operating cash flow
47.78%-222.64K
174,306.87%228.21K
-120.10%-46.61K
76.14%-161.25K
-1,469.12%-243.01K
-760.10%-426.39K
99.89%-131
-55.43%231.86K
-189.04%-675.86K
118.26%17.75K
Investing cash flow
Cash flow from continuing investing activities
101.61%850
0
0
0
850
-1,887.89%-52.7K
-358.88%-49.78K
0
-2.92K
0
Net PPE purchase and sale
-66.00%850
--0
--0
--0
--850
--2.5K
--2.5K
--0
--0
--0
Net intangibles purchas and sale
----
----
----
----
----
-1,982.20%-55.2K
-371.88%-52.28K
--0
----
----
Cash from discontinued investing activities
Investing cash flow
101.61%850
--0
--0
--0
--850
-1,887.89%-52.7K
-358.88%-49.78K
--0
---2.92K
--0
Financing cash flow
Cash flow from continuing financing activities
54.82%211.72K
3,101.87%96.06K
180.62%42.09K
-94.85%193
-36.20%73.38K
-25.87%136.75K
-94.08%3K
-90.19%15K
-75.68%3.75K
433.18%115K
Net issuance payments of debt
59.57%218.21K
3,101.87%96.06K
180.62%42.09K
1,026.67%42.25K
-67.12%37.81K
-24.85%136.75K
-94.08%3K
-90.03%15K
-75.68%3.75K
433.18%115K
Net common stock issuance
----
----
----
---42.06K
--35.57K
----
----
--0
--0
--0
Net other financing activities
---6.49K
--0
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
54.82%211.72K
3,101.87%96.06K
180.62%42.09K
-94.85%193
-36.20%73.38K
-25.87%136.75K
-94.08%3K
-90.19%15K
-75.68%3.75K
433.18%115K
Net cash flow
Beginning cash position
-89.73%16.06K
-98.27%2.44K
102.62%2.64K
-96.73%3.31K
-89.73%16.06K
449.30%156.44K
-31.66%140.87K
76.24%-100.57K
233.13%101.44K
449.30%156.44K
Current changes in cash
97.06%-10.08K
791.19%324.27K
-101.83%-4.51K
76.14%-161.05K
-227.14%-168.78K
-238.93%-342.34K
14.22%-46.91K
-62.14%246.86K
-208.08%-675.03K
200.77%132.75K
Effect of exchange rate changes
-100.18%-363
-312.20%-321.09K
179.84%4.32K
-66.09%160.38K
183.11%156.03K
270.51%201.96K
-1,657.30%-77.9K
76.08%-5.41K
301.67%473.01K
-240.42%-187.75K
End cash Position
-64.99%5.62K
-64.99%5.62K
-98.27%2.44K
102.62%2.64K
-96.73%3.31K
-89.73%16.06K
-89.73%16.06K
-31.66%140.87K
76.24%-100.57K
233.13%101.44K
Free cash from
53.77%-222.64K
535.40%228.21K
-120.10%-46.61K
76.24%-161.25K
-1,469.12%-243.01K
-877.46%-481.59K
50.25%-52.41K
-53.54%231.86K
-189.42%-678.78K
118.26%17.75K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 47.78%-222.64K172,987.12%228.21K-120.10%-46.61K76.14%-161.25K-1,469.12%-243.01K-760.10%-426.39K99.89%-132-55.43%231.86K-189.04%-675.86K118.26%17.75K
Net income from continuing operations 14.20%-1.48M171.16%333.89K-37,161.94%-797.57K45.44%-416.62K-21.21%-601.06K54.58%-1.73M71.44%-469.18K-99.52%2.15K63.43%-763.65K4.79%-495.9K
Operating gains losses 96.09%-789--0--0--096.56%-789-120.97%-20.19K348.79%2.03K-96.06%745--0---22.97K
Depreciation and amortization 94.28%9.89K836.47%6.57K-20.15%1.09K-26.28%1.11K-26.41%1.13K-93.23%5.09K-69.83%702-24.74%1.36K-94.82%1.5K-96.36%1.53K
Asset impairment expenditure --38.82K------------------0----------------
Remuneration paid in stock 270.96%334.11K-124.11%-6.74K2,562.01%308.23K-3.40%19.99K-57.67%12.62K-92.29%90.07K-97.10%27.97K-19.03%11.58K-89.08%20.7K7,280.20%29.82K
Deferred tax --0-----------------232.96%-20.48K----------------
Other non cashItems -41.52%381.81K-269.20%-283.9K268.52%297.71K8.16%84.42K-13.07%283.58K-64.40%652.85K56.19%167.79K-4.12%80.79K-94.80%78.06K133.20%326.22K
Change In working capital -16.52%494.89K-52.04%139.58K6.44%143.94K1,301.97%149.85K-65.64%61.53K-15.10%592.85K-35.35%291.03K371.83%135.23K-122.00%-12.47K-25.78%179.05K
-Change in receivables -106.59%-2.35K34.68%3.18K93.23%-493-118.32%-5.76K-92.10%726486.99%35.72K-60.91%2.36K-157.80%-7.29K281.89%31.47K93.57%9.19K
-Change in prepaid assets -370.15%-26.96K-425.86%-21.77K-238.07%-13.9K170.53%15.17K-143.79%-6.46K-95.13%9.98K-95.04%6.68K177.69%10.07K67.49%-21.51K-90.14%14.74K
-Change in payables and accrued expense -4.19%524.2K-43.91%158.17K19.54%158.33K726.43%140.44K-56.64%67.26K12.31%547.14K-8.89%281.99K368.15%132.45K-116.00%-22.42K78.45%155.12K
Cash from discontinued investing activities
Operating cash flow 47.78%-222.64K174,306.87%228.21K-120.10%-46.61K76.14%-161.25K-1,469.12%-243.01K-760.10%-426.39K99.89%-131-55.43%231.86K-189.04%-675.86K118.26%17.75K
Investing cash flow
Cash flow from continuing investing activities 101.61%850000850-1,887.89%-52.7K-358.88%-49.78K0-2.92K0
Net PPE purchase and sale -66.00%850--0--0--0--850--2.5K--2.5K--0--0--0
Net intangibles purchas and sale ---------------------1,982.20%-55.2K-371.88%-52.28K--0--------
Cash from discontinued investing activities
Investing cash flow 101.61%850--0--0--0--850-1,887.89%-52.7K-358.88%-49.78K--0---2.92K--0
Financing cash flow
Cash flow from continuing financing activities 54.82%211.72K3,101.87%96.06K180.62%42.09K-94.85%193-36.20%73.38K-25.87%136.75K-94.08%3K-90.19%15K-75.68%3.75K433.18%115K
Net issuance payments of debt 59.57%218.21K3,101.87%96.06K180.62%42.09K1,026.67%42.25K-67.12%37.81K-24.85%136.75K-94.08%3K-90.03%15K-75.68%3.75K433.18%115K
Net common stock issuance ---------------42.06K--35.57K----------0--0--0
Net other financing activities ---6.49K--0--------------------------------
Cash from discontinued financing activities
Financing cash flow 54.82%211.72K3,101.87%96.06K180.62%42.09K-94.85%193-36.20%73.38K-25.87%136.75K-94.08%3K-90.19%15K-75.68%3.75K433.18%115K
Net cash flow
Beginning cash position -89.73%16.06K-98.27%2.44K102.62%2.64K-96.73%3.31K-89.73%16.06K449.30%156.44K-31.66%140.87K76.24%-100.57K233.13%101.44K449.30%156.44K
Current changes in cash 97.06%-10.08K791.19%324.27K-101.83%-4.51K76.14%-161.05K-227.14%-168.78K-238.93%-342.34K14.22%-46.91K-62.14%246.86K-208.08%-675.03K200.77%132.75K
Effect of exchange rate changes -100.18%-363-312.20%-321.09K179.84%4.32K-66.09%160.38K183.11%156.03K270.51%201.96K-1,657.30%-77.9K76.08%-5.41K301.67%473.01K-240.42%-187.75K
End cash Position -64.99%5.62K-64.99%5.62K-98.27%2.44K102.62%2.64K-96.73%3.31K-89.73%16.06K-89.73%16.06K-31.66%140.87K76.24%-100.57K233.13%101.44K
Free cash from 53.77%-222.64K535.40%228.21K-120.10%-46.61K76.24%-161.25K-1,469.12%-243.01K-877.46%-481.59K50.25%-52.41K-53.54%231.86K-189.42%-678.78K118.26%17.75K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg